IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $210,723 | -10.1% | 5,896 | -5.0% | 0.00% | -100.0% |
| Q4 2022 | $234,514 | -20.5% | 6,209 | -6.9% | 0.00% | 0.0% |
| Q3 2022 | $295,000 | +32.3% | 6,670 | +10.9% | 0.00% | 0.0% |
| Q2 2022 | $223,000 | -1.3% | 6,016 | -1.5% | 0.00% | – |
| Q1 2022 | $226,000 | -27.1% | 6,106 | +11.3% | 0.00% | -100.0% |
| Q4 2020 | $310,000 | +29.2% | 5,487 | +8.7% | 0.00% | 0.0% |
| Q3 2020 | $240,000 | -25.0% | 5,048 | -6.9% | 0.00% | 0.0% |
| Q2 2020 | $320,000 | +20.3% | 5,421 | -3.5% | 0.00% | -50.0% |
| Q1 2020 | $266,000 | -63.5% | 5,616 | -53.4% | 0.00% | -33.3% |
| Q4 2019 | $729,000 | -31.8% | 12,061 | -32.4% | 0.00% | -50.0% |
| Q3 2019 | $1,069,000 | -24.8% | 17,843 | -19.3% | 0.01% | -25.0% |
| Q2 2019 | $1,421,000 | -25.2% | 22,108 | -5.5% | 0.01% | -20.0% |
| Q1 2019 | $1,900,000 | +38.7% | 23,406 | -7.6% | 0.01% | +25.0% |
| Q4 2018 | $1,370,000 | +2.0% | 25,340 | -2.7% | 0.01% | +14.3% |
| Q3 2018 | $1,343,000 | +23.0% | 26,035 | -0.7% | 0.01% | +16.7% |
| Q2 2018 | $1,092,000 | +11.0% | 26,206 | +17.4% | 0.01% | -14.3% |
| Q1 2018 | $984,000 | -8.6% | 22,329 | +4.4% | 0.01% | 0.0% |
| Q4 2017 | $1,076,000 | -10.3% | 21,394 | -9.6% | 0.01% | -22.2% |
| Q3 2017 | $1,200,000 | +2.5% | 23,663 | +2.8% | 0.01% | 0.0% |
| Q2 2017 | $1,171,000 | +31.6% | 23,017 | +4.0% | 0.01% | +28.6% |
| Q1 2017 | $890,000 | -14.9% | 22,139 | +1.2% | 0.01% | -22.2% |
| Q4 2016 | $1,046,000 | +65.8% | 21,871 | +27.0% | 0.01% | +50.0% |
| Q3 2016 | $631,000 | +53.9% | 17,222 | -2.3% | 0.01% | +50.0% |
| Q2 2016 | $410,000 | -47.6% | 17,619 | -8.8% | 0.00% | -42.9% |
| Q1 2016 | $782,000 | -41.6% | 19,310 | -10.7% | 0.01% | -50.0% |
| Q4 2015 | $1,338,000 | – | 21,612 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |